bisbenzimidazole has been researched along with Neuroectodermal Tumors, Primitive, Peripheral in 1 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
Neuroectodermal Tumors, Primitive, Peripheral: A group of highly cellular primitive round cell neoplasms which occur extracranially in soft tissue and bone and are derived from embryonal neural crest cells. These tumors occur primarily in children and adolescents and share a number of characteristics with EWING SARCOMA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boschman, GA | 1 |
Rens, W | 1 |
Manders, EM | 1 |
Slater, RM | 1 |
Versteeg, R | 1 |
Aten, JA | 1 |
1 other study available for bisbenzimidazole and Neuroectodermal Tumors, Primitive, Peripheral
Article | Year |
---|---|
Detection of recurrent chromosome abnormalities in Ewing's sarcoma and peripheral neuroectodermal tumor cells using bivariate flow karyotyping.
Topics: Bisbenzimidazole; Bone Neoplasms; Chromomycin A3; Chromosome Aberrations; Chromosomes, Human, Pair 1 | 1992 |